• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session

    11/9/22 12:33:19 PM ET
    $ABST
    $AFRM
    $AGFY
    $ALBO
    Finance: Consumer Services
    Finance
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $ABST alert in real time by email

    Gainers

    • Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) shares jumped 219% to $12.80 after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimack is eligible for up to $450 million in milestone payments for the pancreatic cancer treatment.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) shares surged 42.4% to $1.7794. NeuroBo reported closing of $32.3 million underwritten public offering including full exercise of overallotment option and concurrent private placement.
    • Histogen Inc. (NASDAQ:HSTO) jumped 42.6% to $1.4194.
    • Kala Pharmaceuticals, Inc. (NASDAQ:KALA) shares jumped 37.7% to $7.19. On Tuesday, Kala Pharmaceuticals said it swung to a profit for the third quarter.
    • Outset Medical, Inc. (NASDAQ:OM) gained 36.1% to $15.61 after the company reported better-than-expected Q3 results.
    • OptimizeRx Corporation (NASDAQ:OPRX) jumped 28% to $18.58 following better-than-expected Q3 results.
    • Health Catalyst, Inc. (NASDAQ:HCAT) gained 23% to $7.95 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates.
    • Vivint Smart Home, Inc. (NYSE:VVNT) jumped 21.4% to $8.50 after the company posted upbeat quarterly sales and raised FY22 revenue guidance.
    • Quotient Technology Inc. (NYSE:QUOT) rose 21.3% to $3.1903 after the company reported a narrower Q3 loss.
    • LiveRamp Holdings, Inc. (NYSE:RAMP) gained 21% to $18.91 after the company reported better-than-expected Q2 results and issued strong guidance.
    • Axon Enterprise, Inc. (NASDAQ:AXON) jumped 18.2% to $177.25 after the company reported better-than-expected Q3 results.
    • Angi Inc. (NASDAQ:ANGI) jumped 17% to $2.23 following Q3 earnings.
    • A-Mark Precious Metals, Inc. (NASDAQ:AMRK) jumped 17% to $32.76 after the company reported better-than-expected Q1 results.
    • Life Time Group Holdings, Inc. (NYSE:LTH) gained 15.6% to $11.32 following strong Q3 earnings.
    • Array Technologies, Inc. (NASDAQ:ARRY) rose 15.2% to $19.56 after the company reported better-than-expected Q3 results and issued strong guidance.
    • GrowGeneration Corp. (NASDAQ:GRWG) gained 15% to $5.14. GrowGeneration recently reported better-than-expected Q3 sales.
    • Target Hospitality Corp. (NASDAQ:TH) jumped 14.4% to $12.55 after the company reported Q3 EPS results were higher year over year and better-than-expected Q3 sales results. The company authorized up to $100 million in a stock repurchase program.
    • Danimer Scientific, Inc. (NYSE:DNMR) gained 13.8% to $2.7878 following Q3 results.
    • HCI Group, Inc. (NYSE:HCI) jumped 13.8% to $39.38 after reporting a narrower-than-expected quarterly loss.
    • Maiden Holdings, Ltd. (NASDAQ:MHLD) rose 13.2% to $2.41 following Q3 results.
    • Seer, Inc. (NASDAQ:SEER) gained 13.2% to $7.31 after reporting upbeat quarterly results.
    • Sprouts Farmers Market, Inc. (NASDAQ:SFM) jumped 12.2% to $32.17 after the company reported better-than-expected Q3 results and issued guidance above estimates.
    • MRC Global Inc. (NYSE:MRC) gained 11.6% to $10.89 following strong quarterly results.
    • Bit Origin Ltd (NASDAQ:BTOG) gained 11.4% to $0.2395.
    • Forestar Group Inc. (NYSE:FOR) jumped 11.3% to $12.91 following upbeat Q4 results.
    • Coherent Corp. (NASDAQ:COHR) gained 10.8% to $33.18 after the company reported better-than-expected Q1 results.
    • IceCure Medical Ltd (NASDAQ:ICCM) shares rose 10.4% to $1.2701. IceCure Medical announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast cancer cryoablation procedures.
    • Shoals Technologies Group, Inc. (NASDAQ:SHLS) gained 9.8% to $21.63.
    • Ziff Davis, Inc. (NASDAQ:ZD) gained 9.6% to $80.97 following strong quarterly earnings.
    • Hilton Grand Vacations Inc. (NYSE:HGV) gained 9.6% to $41.15 after the company reported better-than-expected Q3 results and raised FY22 EBITDA guidance.
    • XP Inc. (NASDAQ:XP) gained 9.1% to $20.01 after the company reported Q3 financial results.
    • Korea Electric Power Corporation (NYSE:KEP) rose 9% to $6.81.
    • Meta Platforms, Inc. (NASDAQ:META) gained 7.3% to $103.47 after the company announced a planned layoff of 11,000 employees and affirmed Q4 revenue guidance.
    • D.R. Horton, Inc. (NYSE:DHI) rose 6.4% to $77.93 after the company reported Q4 earnings results.


    Losers

    • Clovis Oncology, Inc. (NASDAQ:CLVS) dropped 75% to $0.2365 after the company warned of a possible bankruptcy amid liquidity concerns. The company also reported Q3 earnings results.
    • Telos Corporation (NASDAQ:TLS) shares dipped 65.4% to $3.8246 after the company reported downbeat Q3 earnings and lowered FY22 sales guidance.
    • Athersys, Inc. (NASDAQ:ATHX) dropped 55% to $0.58 after the company announced pricing of a $5.5 million public offering.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) fell 48.1% to $6.40.
    • Timber Pharmaceuticals, Inc. (NASDAQ:TMBR) dropped 41.7% to $1.72 following 1-for-50 reverse stock split.
    • Amyris, Inc. (NASDAQ:AMRS) fell 38.6% to $1.5911 after the company reported worse-than-expected Q3 results.
    • Emergent BioSolutions Inc. (NYSE:EBS) dropped 34.3% to $12.97 after the company reported worse-than-expected Q3 EPS and sales results.
    • Velo3D, Inc. (NYSE:VLD) shares fell 32.7% to $2.27 after the company reported worse-than-expected Q3 results.
    • Arlo Technologies, Inc. (NYSE:ARLO) dropped 32.2% to $3.1750 after the company reported Q3 financial results.
    • Fast Radius, Inc. (NASDAQ:FSRD) fell 30.1% to $0.1195. Fast Radius filed voluntary petitions for relief under Chapter 11.
    • RumbleON, Inc. (NASDAQ:RMBL) dropped 27.7% to $11.33 after the company posted downbeat quarterly earnings and lowered sales guidance.
    • Agrify Corporation (NASDAQ:AGFY) fell 27.6% to $1.0199 after the company reported Q3 EPS and sales results were down year over year.
    • Chart Industries, Inc. (NYSE:GTLS) dipped 27.2% to $174.38 after the company announced it will acquire Howden for $4.4 billion in cash and stock.
    • Centrus Energy Corp. (NYSE:LEU) fell 26.3% to $33.21 after the company reported worse-than-expected Q3 EPS and sales results.
    • Wolverine World Wide, Inc. (NYSE:WWW) dropped 26.2% to $13.32 after the company posted downbeat Q3 results and lowered FY22 forecast.
    • Ascent Industries Co. (NASDAQ:ACNT) dipped 25.5% to $11.15 after reporting a drop in quarterly earnings.
    • Zovio Inc (NASDAQ:ZVO) fell 25% to $0.0899.
    • Eastman Kodak Company (NYSE:KODK) dropped 25% to $4.2650.
    • Porch Group, Inc. (NASDAQ:PRCH) fell 24.7% to $1.0850 following Q3 results.
    • GoodRx Holdings, Inc. (NASDAQ:GDRX) dropped 20.8% to $4.1450 after the company issued Q4 sales guidance below analyst estimates.
    • Electra Battery Materials Corporation (NASDAQ:ELBM) shares fell 20.7% to $2.4285 after the company announced a marketed offering of units for proceeds of up to approximately $8 million.
    • Sweetgreen, Inc. (NYSE:SG) dropped 19.5% to $13.94 after the company reported worse-than-expected Q3 EPS and sales results.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) fell 19.3% to $12.63 after the company reported weaker-than-expected Q1 earnings and issued FY23 sales guidance below analyst estimates.
    • Shift Technologies, Inc. (NASDAQ:SFT) dipped 18.6% to $0.3768 after reporting a Q3 loss.
    • Viasat, Inc. (NASDAQ:VSAT) fell 18.5% to $29.97 after the company reported worse-than-expected Q2 results.
    • Lyell Immunopharma, Inc. (NASDAQ:LYEL) fell 18.4% to $4.47 following Q3 results.
    • Peak Bio, Inc. (NASDAQ:PKBO) fell 18.2% to $4.89 after dipping 19% on Tuesday.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) dipped 18.3% to $22.93, possibly selling-off following recent strength amid reports suggesting Donald Trump could announce a 2024 presidential run.
    • Lucid Group, Inc. (NASDAQ:LCID) fell 17.7% to $11.11 after the company reported downbeat Q3 results.
    • Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) dipped 17.5% to $19.74 following Q3 results.
    • Albireo Pharma, Inc. (NASDAQ:ALBO) dipped 17.3% to $18.30 following wider-than-expected Q3 loss.
    • RadNet, Inc. (NASDAQ:RDNT) dropped 16.8% to $14.20 following weak quarterly earnings.
    • Absolute Software Corporation (NASDAQ:ABST) fell 16.3% to $8.75 following weaker-than-expected Q1 results.
    • TaskUs, Inc. (NASDAQ:TASK) fell 16.1% to $18.47.
    • AerSale Corporation (NASDAQ:ASLE) declined 16.1% to $15.93 after the company reported worse-than-expected Q3 EPS and sales results.
    • Roblox Corporation (NYSE:RBLX) fell 15% to $33.28 after the company reported worse-than-expected Q3 EPS and sales results.
    • The Beauty Health Company (NASDAQ:SKIN) dipped 15% to $9.10 after the company reported Q3 earnings results. JP Morgan downgraded Beauty Health from Overweight to Neutral and lowered the price target from $22 to $11.
    • Upstart Holdings, Inc. (NASDAQ:UPST) shares fell 14.6% to $16.26 after the company reported worse-than-expected Q3 results. The company also issued Q4 sales guidance below analyst estimates.
    • W&T Offshore, Inc. (NYSE:WTI) dropped 14.5% to $7.41 on weak quarterly earnings.
    • Evotec SE (NASDAQ:EVO) shares fell 13.2% to $8.51 after the company reported financial results and corporate updates for the first nine months 2022.
    • Gevo, Inc. (NASDAQ:GEVO) dipped 12% to $1.96 following weak quarterly results.
    • The Walt Disney Company (NYSE:DIS) fell 11.7% to $88.19 after the company reported weaker-than-expected results for its fourth quarter. The company also said average monthly revenue per paid global Disney+ subscriber declined 5% year over year.
    • Robinhood Markets, Inc. (NASDAQ:HOOD) dipped 11.7% to $8.60. Shares of several crypto-related companies traded lower following a CoinDesk report suggesting Binance is leaning toward scrapping the FTX acquisition.
    • GameStop Corp. (NYSE:GME) fell 10.9% to $22.40.
    • CarGurus, Inc. (NASDAQ:CARG) shares fell 10.5% to $12.31 after the company reported worse-than-expected Q3 results. The company also issued Q4 and FY22 EPS and sales guidance below analyst estimates.
    • Helbiz, Inc. (NASDAQ:HLBZ) shares fell 10.5% to $0.1723 after dropping around 8% on Tuesday.
    • Darling Ingredients Inc. (NYSE:DAR) dropped 9.6% to $73.67 after the company reported worse-than-expected Q3 EPS results.
    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) fell 9% to $1.51. Avenue Therapeutics acquired Baergic Bio Inc pursuant to the previously disclosed Share Contribution Agreement with its parent company, Fortress Biotech Inc.
    • Zoom Video Communications, Inc. (NASDAQ:ZM) dropped 8.6% to $71.54.
    • Tidewater Inc. (NYSE:TDW) fell 4% to $31.99 after the company reported pricing of $120.63 million public offering of 3,987,914 shares of common stock at a price of $30.25 per share.
    Get the next $ABST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABST
    $AFRM
    $AGFY
    $ALBO

    CompanyDatePrice TargetRatingAnalyst
    Life Time Group Holdings Inc.
    $LTH
    3/10/2026$40.00Buy
    Jefferies
    Sweetgreen Inc.
    $SG
    3/9/2026Peer Perform
    Wolfe Research
    Lyell Immunopharma Inc.
    $LYEL
    3/9/2026$34.00Mkt Outperform
    Citizens
    Sweetgreen Inc.
    $SG
    3/6/2026$5.50Neutral
    DA Davidson
    Affirm Holdings Inc.
    $AFRM
    3/5/2026$82.00Buy
    BofA Securities
    Meta Platforms Inc.
    $META
    3/5/2026Buy → Neutral
    Arete
    Meta Platforms Inc.
    $META
    3/5/2026Hold → Buy
    Erste Group
    Roblox Corporation
    $RBLX
    3/4/2026$65.00Neutral
    DA Davidson
    More analyst ratings

    $ABST
    $AFRM
    $AGFY
    $ALBO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies initiated coverage on Life Time with a new price target

    Jefferies initiated coverage of Life Time with a rating of Buy and set a new price target of $40.00

    3/10/26 8:41:13 AM ET
    $LTH
    Hotels/Resorts
    Consumer Discretionary

    Wolfe Research initiated coverage on Sweetgreen

    Wolfe Research initiated coverage of Sweetgreen with a rating of Peer Perform

    3/9/26 9:11:59 AM ET
    $SG
    Restaurants
    Consumer Discretionary

    Citizens initiated coverage on Lyell Immunopharma with a new price target

    Citizens initiated coverage of Lyell Immunopharma with a rating of Mkt Outperform and set a new price target of $34.00

    3/9/26 9:07:38 AM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABST
    $AFRM
    $AGFY
    $ALBO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Anderson Joel D bought $339,548 worth of shares (4,400 units at $77.17), increasing direct ownership by 22% to 24,802 units (SEC Form 4)

    4 - Sprouts Farmers Market, Inc. (0001575515) (Issuer)

    3/9/26 8:30:39 PM ET
    $SFM
    Food Chains
    Consumer Staples

    Director Digirolomo Enrico sold $944,506 worth of shares (3,911 units at $241.50) and gifted 1,847 shares, decreasing direct ownership by 27% to 15,599 units (SEC Form 4)

    4 - COHERENT CORP. (0000820318) (Issuer)

    3/9/26 8:17:30 PM ET
    $COHR
    Electronic Components
    Technology

    Chief Concept Officer Jammet Nicolas bought $25,284 worth of shares (4,428 units at $5.71) (SEC Form 4)

    4 - Sweetgreen, Inc. (0001477815) (Issuer)

    3/9/26 5:55:54 PM ET
    $SG
    Restaurants
    Consumer Discretionary

    $ABST
    $AFRM
    $AGFY
    $ALBO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    February 21, 2025 - FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease

    For Immediate Release: February 21, 2025 Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli is the first FDA-approved drug to treat CTX, a very rare lipid storage disease.“The FDA is dedicated to supporting new drug development for rare diseases including very rare metabolic diseases like cerebrotendinous xanthomato

    2/21/25 11:48:20 AM ET
    $MIRM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-11) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 06/10/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    6/13/22 2:20:18 PM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABST
    $AFRM
    $AGFY
    $ALBO
    SEC Filings

    View All

    SEC Form 6-K filed by Korea Electric Power Corporation

    6-K - KOREA ELECTRIC POWER CORP (0000887225) (Filer)

    3/10/26 10:46:15 AM ET
    $KEP
    Electric Utilities: Central
    Utilities

    SEC Form 6-K filed by Electra Battery Materials Corporation

    6-K - Electra Battery Materials Corp (0001907184) (Filer)

    3/10/26 8:30:03 AM ET
    $ELBM
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 10-K filed by AerSale Corporation

    10-K - AerSale Corp (0001754170) (Filer)

    3/10/26 8:01:25 AM ET
    $ASLE
    Industrial Specialties
    Consumer Discretionary

    $ABST
    $AFRM
    $AGFY
    $ALBO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    KBRA Assigns Preliminary Ratings to Upstart Securitization Trust 2026-1

    KBRA assigns preliminary ratings to four classes of notes issued by Upstart Securitization Trust 2026-1 ("UPST 2026-1"), a $292.21 million consumer loan ABS securitization collateralized by unsecured consumer loans and auto secured personal loans. UPST 2026-1 represents the 49th ABS securitization collateralized by loans originated through the online platform operated by Upstart Network, Inc. ("Upstart" or the "Company"), a 100% owned subsidiary of the publicly traded entity Upstart Holdings, Inc. (NASDAQ:UPST). The preliminary ratings reflect initial credit enhancement levels of 60.65% for the Class A-1 and Class A-2 notes, 46.85% for the Class B notes, 35.90% for the Class C notes and 2

    3/10/26 11:47:00 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    The Race for Uranium Has Gone Global

    VANCOUVER, British Columbia, March 10, 2026 (GLOBE NEWSWIRE) -- USANewsgroup.com News Commentary — The United States currently imports roughly 95% of the uranium it consumes, leaving the world's largest nuclear fleet almost entirely dependent on foreign fuel[1]. In January 2026, the White House issued a Section 232 proclamation formally designating uranium a national security risk, opening the door to import restrictions, price floors, and direct federal support for domestic miners[2]. Eagle Nuclear Energy Corp. (NASDAQ:NUCL), Cameco (NYSE:CCJ) (TSX:CCO), Denison Mines (NYSE-A: DNN) (TSX:DML), Centrus Energy (NYSE:LEU), and NuScale Power (NYSE:SMR) are each advancing projects that strength

    3/10/26 9:15:00 AM ET
    $CCJ
    $LEU
    $NUCL
    Other Metals and Minerals
    Basic Materials
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    PCI Pal Advances AI-Driven Customer Engagement with Secure Payment Experiences for Zoom Virtual Agent

    Embedded secure payments designed to enable seamless AI-powered interactions without increasing compliance scope PCI Pal® (LON: PCIP), a global provider of secure payment and customer interaction solutions, today announced an expansion of its strategic relationship with Zoom Communications, Inc. (NASDAQ:ZM), with an agreement to accelerate support for Zoom Virtual Agent (ZVA). The planned integration will embed PCI Pal's secure payment technology directly into Zoom's advanced virtual agent, enabling seamless, secure customer interactions within AI-driven workflows. Zoom Virtual Agent introduces expanded AI capabilities designed to resolve customer issues end to end, seamlessly hand off

    3/10/26 9:02:00 AM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    $ABST
    $AFRM
    $AGFY
    $ALBO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Anderson Joel D bought $339,548 worth of shares (4,400 units at $77.17), increasing direct ownership by 22% to 24,802 units (SEC Form 4)

    4 - Sprouts Farmers Market, Inc. (0001575515) (Issuer)

    3/9/26 8:30:39 PM ET
    $SFM
    Food Chains
    Consumer Staples

    Chief Concept Officer Jammet Nicolas bought $25,284 worth of shares (4,428 units at $5.71) (SEC Form 4)

    4 - Sweetgreen, Inc. (0001477815) (Issuer)

    3/9/26 5:55:54 PM ET
    $SG
    Restaurants
    Consumer Discretionary

    Large owner Arch Venture Partners Ix, Llc bought $12,499,985 worth of shares (488,090 units at $25.61) (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    3/9/26 4:36:20 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABST
    $AFRM
    $AGFY
    $ALBO
    Leadership Updates

    Live Leadership Updates

    View All

    Coherent to Join the S&P 500

    SAXONBURG, Pa., March 09, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE:COHR) ("Coherent," "We," or the "Company"), a global leader in photonics, today announced it will join the S&P 500 index, effective Monday, March 23. Jim Anderson, CEO, said, "Joining the S&P 500 is a testament to the strength of our team, the power of our technology portfolio, and the trust our customers have placed in us. As optical interconnects and photonic solutions become foundational to scaling next-generation AI data center infrastructure, Coherent is uniquely positioned to drive innovation and deliver enhanced value to our shareholders." Regarded as the leading benchmark for U.S. large-cap equities, the S&P

    3/9/26 9:06:18 AM ET
    $COHR
    Electronic Components
    Technology

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors

    GAITHERSBURG, Md., March 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of John D. Fowler, Jr. to its board of directors effective March 1, 2026. Mr. Fowler brings more than three decades of leadership experience across the healthcare and financial services sectors. He will serve on the Audit and Finance Committee. "We're pleased to welcome John to the board of directors at this important point in the company's ongoing turnaround and transformation," said Dr. Zsolt Harsanyi, Ph.D., chairman of the board. "John's deep experience in healthcare and financial markets will provide valuable insight as the company continues to execute against i

    3/3/26 8:00:00 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABST
    $AFRM
    $AGFY
    $ALBO
    Financials

    Live finance-specific insights

    View All

    IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026

    CAESAREA, Israel, March 10, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that it will issue a press release with its financial and operational results as of and for the twelve months ended December 31, 2025 before the Nasdaq Stock Market opens on Tuesday, March 17, 2026. The Company will also discuss such results and other corporate developments on a conference call at 11:00 a.m. EDT on the same day. Conference call & webcast info:Tuesday, March 17, 2026, at 11:00 am EDTUS: 1-888-407-2553Is

    3/10/26 8:30:00 AM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

    -   Q4 revenue of $32.2 million-   Q4 gross profit increased 9% year-over-year to $24.1 million-   Q4 net income and adjusted EBITDA hit records at $5.0 million and $12.0 million, respectively-   Updating 2026 revenue guidance to $109-$114 million and adjusted EBITDA guidance to $21-$25 million-   Paid off an incremental $2 million in principal from term loan during Q4-   OptimizeRx's Board authorizes a $10 million share repurchase program  WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today

    3/5/26 5:04:30 PM ET
    $OPRX
    Real Estate

    W&T Offshore, Inc. Declares First Quarter 2026 Dividend

    HOUSTON, March 05, 2026 (GLOBE NEWSWIRE) -- W&T Offshore, Inc. (NYSE:WTI) (the "Company") today announced that its Board of Directors has approved and declared its quarterly cash dividend of $0.01 per share of common stock for the first quarter of 2026 which is payable on March 26, 2026 to stockholders of record on March 19, 2026. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors. Tracy W. Krohn, W&T's Chairman of the Board and Chief Executive Officer, commented, "We are pleased to announce our first quarter 2026 dividend, marking our ninth consecutive quarterly dividend. We remain committe

    3/5/26 4:45:00 PM ET
    $WTI
    Oil & Gas Production
    Energy

    $ABST
    $AFRM
    $AGFY
    $ALBO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by RumbleOn Inc.

    SC 13D/A - RumbleOn, Inc. (0001596961) (Subject)

    12/10/24 9:00:06 PM ET
    $RMBL
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by OptimizeRx Corporation

    SC 13G/A - OptimizeRx Corp (0001448431) (Subject)

    12/6/24 4:26:03 PM ET
    $OPRX
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Agrify Corporation

    SC 13D/A - Agrify Corp (0001800637) (Subject)

    11/29/24 4:30:03 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples